Clinical Trial Update: The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating topical vitamin D and supplementation for acne vulgaris, examining VDR and inflammatory cytokine expression (IL-1β, IL-6, IL-10, IL-17)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• topical vitamin D (vitamin D)

Snippet

Sponsor: Indonesia University | Conditions: Acne Vulgaris, Vitamin D | Phase 4 | Status: UNKNOWN